2016 GU Public Saturday

Bernard J. Escudier, MD, presenting Abstract 499 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Bernard J. Escudier, MD, presenting Abstract 499 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Robert J. Motzer, MD, presents Abstract 498 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Robert J. Motzer, MD, presents Abstract 498 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Bernard J. Escudier, MD, presenting Abstract 499 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Bernard J. Escudier, MD, presenting Abstract 499 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Robert J. Motzer, MD, presenting Abstract 498 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Robert J. Motzer, MD, presenting Abstract 498 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Robert J. Motzer, MD, presenting Abstract 498 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Robert J. Motzer, MD, presenting Abstract 498 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Thai Huu Ho, MD, PhD, presenting Abstract 591 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Thai Huu Ho, MD, PhD, presenting Abstract 591 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Thai Huu Ho, MD, PhD, presenting Abstract 591 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Thai Huu Ho, MD, PhD, presenting Abstract 591 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Edwin Jason Abel, MD, presenting Abstract 496 - General Session 8: Healthcare Outcomes in Renal Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Edwin Jason Abel, MD, presenting Abstract 496 during General Session 8: Healthcare Outcomes in Renal Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Hans J. Hammers, MD, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Hans J. Hammers, MD, PhD gives keynote talk​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Hans J. Hammers, MD, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Hans J. Hammers, MD, PhD gives keynote talk​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

General Views

San Francisco, CA - 2016 GU Cancers Symposium - General Views at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Hans J. Hammers, MD, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Hans J. Hammers, MD, PhD gives keynote talk​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Hans J. Hammers, MD, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Hans J. Hammers, MD, PhD and Gordon J. Freeman, PhD, during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Hans J. Hammers, MD, PhD with Daniel Hamstra, MD, PhD - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Hans J. Hammers, MD, PhD with Daniel Hamstra, MD, PhD​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Gordon J. Freeman, PhD with Daniel Hamstra, MD, PhD - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Gordon J. Freeman, PhD with Daniel Hamstra, MD, PhD​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Gordon J. Freeman, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Gordon J. Freeman, PhD gives keynote talk​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Gordon J. Freeman, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Gordon J. Freeman, PhD gives keynote talk​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Gordon J. Freeman, PhD gives keynote talk​ - Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​

San Francisco, CA - 2016 GU Cancers Symposium - Gordon J. Freeman, PhD gives keynote talk​ during Renal Cancer Keynote Lectures: Immune Checkpoint Blockers - Science and Clinic​ at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Daniel A. Hamstra, MD, PhD, delivers the welcome - General Session 7

San Francisco, CA - 2016 GU Cancers Symposium - Daniel A. Hamstra, MD, PhD, delivers the welcome during General Session 7 at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Daniel A. Hamstra, MD, PhD, delivers the welcome - General Session 7

San Francisco, CA - 2016 GU Cancers Symposium - Daniel A. Hamstra, MD, PhD, delivers the welcome during General Session 7 at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Daniel A. Hamstra, MD, PhD, delivers the welcome - General Session 7

San Francisco, CA - 2016 GU Cancers Symposium - Daniel A. Hamstra, MD, PhD, delivers the welcome during General Session 7 at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Brian M. Shuch, MD speaks - Best of Journals: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Brian M. Shuch, MD speaks during Best of Journals: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Brian M. Shuch, MD speaks - Best of Journals: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Brian M. Shuch, MD speaks during Best of Journals: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016

Bernard J. Escudier, MD, presenting Abstract 499 - Oral Abstract Session C: Renal Cell Cancer

San Francisco, CA - 2016 GU Cancers Symposium - Bernard J. Escudier, MD, presenting Abstract 499 during Oral Abstract Session C: Renal Cell Cancer at the 2016 Genitourinary Cancers Symposium here today, Saturday, January 9, 2016. The conference is the premier meeting on the science and treatment of genitourinary cancers from basic research to patient-based studies to larger clinical trials and population analyses in the United States. More than 3,100 experts from around the world are attending the meeting which is sponsored by the American Society of Clinical Oncology, the American Society of Radiation Oncology and the Society of Urologic Oncology. Photo by © ASCO/Todd Buchanan 2016